Skip to Navigation
London School of Hygiene & Tropical Medicine Malaria Centre

Malaria Programs at Risk From Funding Cuts


21 December 2012
Professor Brian Greenwood comments on increased resistance to artemisinins: Voice of America story

Malaria Programs at Risk From Funding Cuts

Funding for programs to control malaria and provide universal treatment for the mosquito-borne disease is falling short of international goals, according to the World Health Organization. In it's annual report, the WHO also warns that the latest drugs could soon become ineffective against some deadly malarial parasites.  

Professor Greenwood comments

The greatest concern is the growing resistance of the malarial parasite to the latest medicines known as artemisinins.

“We do have now quite clear evidence that there is resistance to the artemisinins, particularly in Cambodia, but probably in the neighboring countries. Fortunately not yet in Africa, but it would be a disaster if those parasites got loose in Africa, and our main treatment was failing again, like it did with chloroquin,” he said.

Until an effective malaria vaccine is developed and made available globally, researchers say it is vital that donors continue to fund prevention and treatment programs that have made such progress until now. 

View the full Voice of America story and video here